RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 7, Issue 12, Pages e2572-e2572
Publisher
Springer Nature
Online
2016-12-29
DOI
10.1038/cddis.2016.436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
- (2015) Yang-Fan Lv et al. Scientific Reports
- Epigenetic silencing of methyl-CpG-binding protein 2 gene affects proliferation, invasion, migration, and apoptosis of human osteosarcoma cells
- (2014) Gang Meng et al. TUMOR BIOLOGY
- Anoikis molecular pathways and its role in cancer progression
- (2013) Paolo Paoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells
- (2013) Yi Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Cooperative role of RanBP9 and P73 in mitochondria-mediated apoptosis
- (2013) T Liu et al. Cell Death & Disease
- TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells
- (2012) Yusheng Huang et al. APOPTOSIS
- The Maternally Expressed GeneTssc3Regulates the Expression of MASH2 Transcription Factor in Mouse Trophoblast Stem Cells through the AKT-Sp1 Signaling Pathway
- (2012) Tomoka Takao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RanBPM Is an Inhibitor of ERK Signaling
- (2012) Elnaz Atabakhsh et al. PLoS One
- TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma
- (2011) Huanzi Dai et al. CARCINOGENESIS
- Diverse roles of the scaffolding protein RanBPM
- (2011) Bharathi Suresh et al. DRUG DISCOVERY TODAY
- Anoikis: an emerging hallmark in health and diseases
- (2011) ML Taddei et al. JOURNAL OF PATHOLOGY
- EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients
- (2010) Zhi-Yue Rao et al. CARCINOGENESIS
- Stability and Function of Mammalian Lethal Giant Larvae-1 Oncoprotein Are Regulated by the Scaffolding Protein RanBPM
- (2010) Bharathi Suresh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting anoikis resistance in prostate cancer metastasis
- (2010) Shinichi Sakamoto et al. MOLECULAR ASPECTS OF MEDICINE
- Understanding Micrometastatic Disease and Anoikis Resistance in Ewing Family of Tumors and Osteosarcoma
- (2010) S. J. Strauss et al. ONCOLOGIST
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
- (2009) Tatsuya Kawase et al. CELL
- Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo
- (2009) P. Hingorani et al. CLINICAL CANCER RESEARCH
- RanBPM Has Proapoptotic Activities That Regulate Cell Death Pathways in Response to DNA Damage
- (2009) E. Atabakhsh et al. MOLECULAR CANCER RESEARCH
- Anoikis: A necessary death program for anchorage-dependent cells
- (2008) Paola Chiarugi et al. BIOCHEMICAL PHARMACOLOGY
- Transcriptional up-regulation of PHLDA1 by 17β-estradiol in MCF-7 breast cancer cells
- (2008) A.C. Marchiori et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Anoikis resistance and tumor metastasis
- (2008) Craig D. Simpson et al. CANCER LETTERS
- Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma
- (2008) Yi Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started